The curious case of Mutua's super-sized ambition
He's a man who never misses chance to sway public opinion towards himself
Source: Standard Digital
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




